Leading U.S. urologists Aaron Katz, MD, Jed Kaminetsky, MD, and Maria Betancourt, MD along with Healthy Bladder Plus™ Release Positive Clinical Trial Results

Share Article

Leading U.S. urologists Aaron Katz, MD, Jed Kaminetsky, MD, and Maria Betancourt, MD along with Healthy Bladder Plus™ announce results of a clinical trial of a remarkably effective new dietary supplement for bladder control related to overactive bladder.

News Image
We are extremely pleased to see this level of effectiveness in the data generated from this 12 week trial. The 72.6% response rate among the women in this trial is not something you typically see in an herbal supplement

In a study under the direction of Nutraceutical Medical Research, by noted urologists Aaron Katz, MD, Jed Kaminetsky, MD, and Maria Betancourt, MD, the all natural herbal and mineral blend known as Healthy Bladder Plus™ was shown to be safe and extremely effective with results equal or exceeding those typically shown in pharmaceutical clinical trials.

“We are extremely pleased to see this level of effectiveness in the data generated from this 12 week trial. The 72.6% response rate among the women in this trial is not something you typically see in an herbal supplement. What we are seeing here are indications of pharmaceutical grade effectiveness,” said lead researcher and professor of urology at Stony Brook University School of Medicine, Dr. Aaron Katz.

Participants in the clinical trial were all women varying from ages 30 to 75 who showed bothersome symptoms of overactive bladder (OAB). Their conditions included urinary frequency, urinary inconsistency, nocturia (nighttime waking to use the bathroom), and urinary urgency. The trial was conducted at four major medical centers in the New York area: 1) New York University Hospital 2) Manhattan Medical Research 3) Icahn School of Medicine Research at Mount Sinai and 4) University Hospital, Garden City.

Participants took Healthy Bladder Plus orally twice daily for 12 weeks. They were evaluated using the OAB-QL short form, the Patient Global Impression of Improvement Scale (PGI-I), the Patient Global Impression of Severity Scale (PGI-S) and 3-day bladder diaries. Patients were assessed for vital signs, adverse events, and changes in urinary urgency, frequency, incontinence episodes and nocturia.

Results showed no serious adverse events from taking the study agent. One episode of headache was noted, as was once episode of mild upset stomach. These events resolved on their own and no one withdrew from the study as a result. It is considered unlikely that either event was related to taking the study agent.

The average number of nighttime bathroom trips was reduced 39% from baseline, with a p value of 0.04. Average number of urgency related incontinence events was reduced by 35% and average daily bathroom trips (micturitions) was reduced by 25% p=0.041). There were no events of dry mouth, constipation, or hypertension. This is particularly important to note, as those side effects are common with anti-muscarinic drugs, as well as miragebron.

“The stellar safety profile in this Healthy Bladder Plus trial, combined with the excellent efficacy data makes Healthy Bladder Plus a game changer in the world of overactive bladder. This is incredibly important for the 30 million American women who suffer from this debilitating condition”, said Charles Ripps, maker of Healthy Bladder Plus.

Individuals interested in learning more about Healthy Bladder Plus can visit the website at http://healthybladder.com/.

About Healthy Bladder Plus™
Many women who are 30 years of age or older will experience some sort of incontinence in their lifetime. OAB is one form of incontinence that many women struggle with on a daily basis. Healthy Bladder Plus creates products for women that not only relieve them of many of their OAB symptoms, but gives them their life back as well.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Farra Larimore for Healthy Bladder Plus™
Healthy Bladder Plus™
+1 (970) 541-3284 Ext: 3284
Email >
Visit website

Media